Addex Therapeutics (ADXN) Shares Outstanding (2018 - 2026)

Addex Therapeutics has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $894762.0 in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 9.44% year-over-year to $894762.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $894762.0 (up 9.44% YoY) and the FY2025 annual result came in at $894762.0, up 9.44% from the prior year.
• Shares Outstanding (Entity) improved to $894762.0 in Q4 2025 per ADXN's latest filing, from $837694.0 in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $150.6 million in Q4 2022 and troughed at $619230.0 in Q4 2023.
• A 5-year average of $51.9 million and a median of $6.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 32.43% in 2022, then tumbled 99.59% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $113.7 million in 2021, then surged by 32.43% to $150.6 million in 2022, then sank by 99.59% to $619230.0 in 2023, then jumped by 32.04% to $817607.0 in 2024, then gained by 9.44% to $894762.0 in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $894762.0, $837694.0, and $817607.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.